Rachel Murray

1 POSTS 0 COMMENTS
Rachel Murray is Head of Partnerships and Strategist for Fountain Partnership. With a background in sales and digital marketing for both B2B and B2C, Rachel has a proven track record of achieving growth for her clients. Her ability to put forward a clear case for investment in digital marketing has led to Rachel delivering key speeches to senior decision makers from top brands across the UK, including Google HQ.

Latest articles

PM Society Digital Awards Winners 2021

PM Society Digital Awards Winners 2021

Winners from the 12th PM Society Digital Awards have been announced after the event was held online for the second year in a row,...
New patient coalition launched for digital health technology

New patient coalition launched for digital health technology

A new coalition with members from Royal Colleges, health charities and patient groups has come together to ensure the interests of patients are at the...
How to digitalise MSL teams for increased efficiency

How to digitalise MSL teams for increased efficiency

Medical Science Liaison (MSL) teams in the pharma industry were already at the limit pre-Covid. Products were complex, wider engagement from healthcare professionals (HCPs)...

Popular articles

Image of a person descending a ladder over coronavirus to show New Normal, New Thinking: Life Post COVID-19

New Normal, New Thinking: Life Post COVID-19

New thinking will be required to adapt to the new normal life post COVID-19. I hate to start this article on a negative note, but...
New patient coalition launched for digital health technology

New patient coalition launched for digital health technology

A new coalition with members from Royal Colleges, health charities and patient groups has come together to ensure the interests of patients are at the...
PM Society Digital Awards Winners 2021

PM Society Digital Awards Winners 2021

Winners from the 12th PM Society Digital Awards have been announced after the event was held online for the second year in a row,...
Sandoz in commercial agreement with Bio-Thera Solutions for biosimilar bevacizumab

Sandoz in commercial agreement with Bio-Thera Solutions for biosimilar bevacizumab

Sandoz, a Novartis division, has strengthened its pipeline by entering into a commercialization agreement with Bio-Thera Solutions, Ltd. for biosimilar bevacizumab (BAT1706) for the...
How to digitalise MSL teams for increased efficiency

How to digitalise MSL teams for increased efficiency

Medical Science Liaison (MSL) teams in the pharma industry were already at the limit pre-Covid. Products were complex, wider engagement from healthcare professionals (HCPs)...

Subscribe

Sign up to receive your free UK subscription to Pf Magazine and our digital newsletters, for all the essential headlines, Jobs of the Week, and thought-provoking features.

Claim my free subscription